BMS has partnered with Nektar Therapeutics in a clinical collaboration that aims to boost the efficacy of Opdivo with Nektar candidate NKTR-214.

Amgen’s Kyprolis has come up short against Takeda’s Velcade in a Phase III trial in patients newly diagnosed with multiple myeloma.

​​​​​​​Kite Pharma has posted an interim analysis of Phase II CAR-T data it thinks are strong enough to support regulatory approval.

Roche unveiled a new app for patients on anticoagulation therapy, allowing them to see results from their at-home blood clotting tests on an iOS device.

iRhythm, the maker of the Zio wearable heart monitor, plans an initial public offering to raise up to $86 million it will use to step up the commercial and…

BrainScope got FDA clearance for its handheld medical device for diagnosing traumatic brain injury. The news is a feather in the company’s cap as it builds out…

Mologen is seeking to raise €16 million to fund a suite of trials of its TLR9 agonist in patients with colorectal cancer, small cell lung cancer and HIV.

IBM and the Ontario Centres of Excellence launched a startup hub in Toronto this week, enrolling e-health player Analytics 4 Life as its first participant.

Intrexon has done deals with two of the portfolio companies from a fund dedicated to promoting the use of the synthetic biology player's tech: Genten…